Chandan Healthcare Ltd
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
- Market Cap ₹ 576 Cr.
- Current Price ₹ 236
- High / Low ₹ 358 / 185
- Stock P/E 21.6
- Book Value ₹ 68.5
- Dividend Yield 0.00 %
- ROCE 22.8 %
- ROE 19.0 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 102% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 86.9 days to 166 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of Nifty SME Emerge
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 67 | 56 | 72 | 76 | 100 | 129 | 157 | 167 | |
| 60 | 51 | 69 | 67 | 74 | 92 | 110 | 116 | |
| Operating Profit | 6 | 5 | 3 | 9 | 25 | 37 | 46 | 51 |
| OPM % | 9% | 9% | 3.8% | 12% | 25% | 29% | 30% | 30% |
| 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | |
| Interest | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 7 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 6 | 10 | 11 |
| Profit before tax | 2 | 1 | -1 | 5 | 21 | 28 | 34 | 34 |
| Tax % | 39% | 45% | 93% | 23% | 24% | 26% | 25% | |
| 1 | 1 | -1 | 4 | 16 | 21 | 25 | 25 | |
| EPS in Rs | 0.71 | 0.41 | -0.68 | 2.02 | 8.01 | 8.50 | 10.36 | 10.13 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 27% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 102% |
| 3 Years: | 89% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -1% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 25% |
| Last Year: | 19% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 24 | 24 |
| Reserves | 4 | 5 | 3 | 7 | 21 | 96 | 143 |
| 15 | 14 | 15 | 17 | 29 | 33 | 39 | |
| 20 | 18 | 22 | 26 | 23 | 23 | 26 | |
| Total Liabilities | 59 | 56 | 59 | 70 | 93 | 177 | 232 |
| 20 | 20 | 25 | 28 | 44 | 71 | 96 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 4 | 12 |
| Investments | 20 | 11 | 14 | 15 | 13 | 10 | 24 |
| 19 | 25 | 21 | 27 | 37 | 91 | 100 | |
| Total Assets | 59 | 56 | 59 | 70 | 93 | 177 | 232 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| -7 | 7 | 5 | 6 | -19 | 24 | ||
| 7 | -10 | -2 | -15 | -36 | -50 | ||
| -0 | -2 | -2 | 9 | 60 | 23 | ||
| Net Cash Flow | 0 | -4 | 1 | -1 | 6 | -3 | |
| Free Cash Flow | -7 | 1 | -0 | -13 | -57 | -17 | |
| CFO/OP | -121% | 274% | 61% | 37% | -31% | 70% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 76 | 53 | 77 | 80 | 88 | 103 |
| Inventory Days | 88 | 78 | 37 | 9 | 204 | ||
| Days Payable | 126 | 224 | 233 | 399 | 127 | ||
| Cash Conversion Cycle | 15 | -69 | -143 | -314 | 80 | 88 | 181 |
| Working Capital Days | -66 | -10 | -60 | -67 | -14 | 108 | 166 |
| ROCE % | 9% | 2% | 18% | 41% | 28% | 23% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Number of Collection Centers count |
|
||||
| Number of Diagnostic Centers & Labs count |
|||||
| Pathology Revenue Share % |
|||||
| Total Tests Conducted Lakhs |
|||||
| B2C (Retail Diagnostics) Revenue Share % |
|||||
| B2G (Government PPPs) Revenue Share % |
|||||
| Total Patient Count Lakhs |
|||||
| Number of Franchise Centers count |
|||||
Extracted by Screener AI
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
- Chandan Healthcare shared Q1 FY27 results, 53.56% pharmacy divestment, and expansion plans.
-
Analysts/Institutional Investor Meet/Con. Call Updates
- Audio recording of Q1 FY26-27 earnings conference call made available on August 18, 2026.
-
Investor Presentation
- Chandan Healthcare Limited has informed about Investor Presentation
-
Outcome of Board Meeting
- Board approved Q1 FY27 results on 14 Aug 2026; standalone profit ₹670.89 lakh, consolidated ₹749.50 lakh; first-time Ind AS.
-
Monitoring Agency Report
- Crisil report confirms June 2026 utilization of preferential warrant proceeds had no deviations.
Concalls
-
Aug 2026Transcript PPT REC
-
Jun 2026Transcript PPT REC
-
Feb 2026Transcript PPT
-
Dec 2025Transcript PPT
-
Nov 2025TranscriptPPT REC
-
Aug 2025TranscriptAI SummaryPPT
Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points.